IP Library Granted Patent US 10,495,429
Granted Patent B2
US 10,495,429 · App. 15/871,697 · Granted Dec 3, 2019

Biocompatible ammunition

Inventors: Benjamin Omonira (Katy, TX); Jonathan Omonira (Katy, TX)
Assignee: Lazarus Solutions LLC
F42B12/54F42B12/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,495,429
App. No.
15/871,697
Granted
Dec 3, 2019
Kind
B2
Abstract

In one embodiment, a small arms projectile is described, including a shell and a hemostatic material retained within the shell, wherein the projectile is configured such that the hemostatic material is released upon an impact of the projectile. In some embodiments, the hemostatic material includes one or more of a factor concentrator, a mucoadhesive agent, and a procoagulant supplementor. In some embodiments, the hemostatic material may be configured as an expandable foam, a sponge, a hydrogel, a powder, a compound, a mixture, a suspension, or any combination thereof. In some embodiments, the hemostatic agent is further treated with one or more cauterizing agents, paralytic agents, anesthetic agents, and sedative agents.

Claims (31)

1. A small arms projectile, comprising:

a shell, having an interior and an exterior, wherein the shell comprises a plurality of perforations, and wherein the perforations are configured to provide, upon an impact of the projectile, fluid communication between the hemostatic material and the exterior of the shell via the plurality of perforations; and

a hemostatic material retained in the interior of the shell.

2. The small arms projectile of claim 1 , wherein the hemostatic material comprises one or more materials selected from the group consisting of: an expandable foam, a sponge, a hydrogel, a powder, and a metal.

3. The small arms projectile of claim 1 , wherein the hemostatic material further comprises one or more agents selected from the group consisting of: a paralytic agent, an anesthetic agent, and a sedative agent.

4. The small arms projectile of claim 1 , wherein the shell further comprises:

a first plurality of structural regions; and

a second plurality of structural regions interlaced with the first plurality of structural regions,

wherein a stress concentration upon impact is higher in the second plurality of structural regions than a stress concentration upon impact in the first plurality of structural regions.

5. The small arms projectile of claim 4 , wherein the first plurality of structural regions has a first radial thickness and the second plurality of structural regions has a second radial thickness, wherein the first radial thickness is less than the second radial thickness.

6. The small arms projectile of claim 1 , wherein the shell further comprises:

a depression in a tip portion of the shell.

7. A small arms cartridge, comprising:

a cartridge case having an open end, a closed end, and a longitudinal axis; a shell, having an interior and an exterior, the shell configured for secure retention in the open end of the cartridge case, wherein the shell includes a plurality of perforations, and wherein the perforations are configured to provide, upon an impact of the projectile, fluid communication between the hemostatic material and the exterior of the shell via the plurality of perforations;

a propellant retained within the cartridge case between the shell and the closed end of the cartridge case; and

an enclosed material retained in the interior of the shell,

wherein the enclosed material is configured as a hemostatic material.

8. The small arms cartridge of claim 7 , wherein the shell includes one or more channels, and wherein the enclosed material is in fluid communication with the exterior of the shell through the one or more channels.

9. The small arms cartridge of claim 8 , wherein at least some of the the plurality of perforations are configured as microscopic perforations.

10. The small arms cartridge of claim 7 , wherein the enclosed material comprises one or more material selected from the list consisting of: an expandable foam, a sponge, a hydrogel, a powder, and a metal.

11. The small arms cartridge of claim 7 , wherein the enclosed material comprises one or more agents selected from the list consisting of: a paralytic agent, an anesthetic agent, and a sedative agent.

12. The small arms cartridge of claim 7 , wherein the shell further comprises:

a first plurality of structural regions; and

a second plurality of structural regions interlaced with the first plurality of structural regions,

wherein a stress concentration upon impact is higher in the second plurality of structural regions than a stress concentration upon impact in the first plurality of structural regions.

13. The small arms cartridge of claim 12 , wherein the first plurality of structural regions has a first radial thickness and the second plurality of structural regions has a second radial thickness, wherein the first radial thickness is less than the second radial thickness form a continuous interior surface.

14. The small arms cartridge of claim 7 , wherein the shell further comprises:

a depression in a tip portion of the shell.

15. The small arms cartridge of claim 7 , further comprising:

a piezoelectric material;

an electrical circuit including an open switch, wherein the switch is configured to be closed responsive to compression of the piezoelectric material.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2019
From: OMONIRA, BENJAMIN; OMONIRA, JONATHAN
To: LAZARUS SOLUTIONS LLC
Reel/Frame 050689/0586 →
Continuity (2)
Provisional Application 62446442 · Jan 15, 2017
Related Publication 20180202785A1 · Jul 19, 2018